Edwards Lifesciences
EW
$73.83
Share price
-0.20%
Change (1 day)
-16.90%
Change (1 year)
Categories
Operating Margin for Edwards Lifesciences (EW)
Operating Margin as of June 2025 (TTM): 29.29%
According to Edwards Lifesciences's latest financial reports and stock price the company's current Operating Margin is 29.29%. At the end of 2024 the company had an Operating Margin of 28.46%.
Operating Margin history for Edwards Lifesciences from 2001 to 2025
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2024 | 28.46% | 3.9% |
| 2023 | 27.39% | -19.52% |
| 2022 | 34.04% | 4.65% |
| 2021 | 32.53% | 55.64% |
| 2020 | 20.90% | -22.1% |
| 2019 | 26.83% | 31.18% |
| 2018 | 20.45% | -32.11% |
| 2017 | 30.13% | 21% |
| 2016 | 24.90% | -0.24% |
| 2015 | 24.96% | -49.32% |
| 2014 | 49.25% | 97.06% |
| 2013 | 24.99% | 22.29% |
| 2012 | 20.44% | 20.96% |
| 2011 | 16.90% | -8.85% |
| 2010 | 18.53% | -19.54% |
| 2009 | 23.04% | 73.43% |
| 2008 | 13.28% | -3.25% |
| 2007 | 13.73% | -17.37% |
| 2006 | 16.62% | 42.08% |
| 2005 | 11.69% | 261.91% |
| 2004 | 3.23% | -70.04% |
| 2003 | 10.78% | 35.58% |
| 2002 | 7.95% | -711.7% |
| 2001 | -1.30% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Boston Scientific BSX | 14.12% | -51.79% | 🇺🇸 USA |
 Merit Medical MMSI | 11.05% | -62.27% | 🇺🇸 USA |
 LeMaitre Vascular LMAT | 25.77% | -12.02% | 🇺🇸 USA |
 CryoLife CRY | 0.69% | -97.65% | 🇺🇸 USA |
 Medtronic MDT | 14.94% | -48.99% | 🇮🇪 Ireland |
 ICU Medical
ICUI | -2.77% | -109.46% | 🇺🇸 USA |
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.